EUVIMEDEUVIMED entdecken
Crossref

2071-P: Gastric Emptying in Youth on Glucagon-Like Peptide 1 Receptor Agonists

NATALIE SEGEV, ISABELLE G. ALLEN, NANA YAYAH JONES, AMY SHAH, SURYAKUMAR NARAYANASAMY

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2071-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von NATALIE SEGEV und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Glucagon-like peptide-1 receptor agonists (GLP1) treat obesity and type 2 diabetes (T2D) by mimicking incretins, reducing appetite through delayed gastric emptying. This raises concern for retained gastric contents (GC) during sedated procedures which may increase aspiration risk. Adult studies demonstrate solid retention despite fasting, prompting a variety of recommendations to hold GLP1s before procedures. Pediatric data are lacking. We evaluated gastric emptying in youth on GLP1s, to inform preoperative management.

Methods

Diabetes status, GLP1 use, and fasting duration were recorded. Point-of-care ultrasound assessed GC. Groups were compared using t-tests and Fisher’s exact tests. Multivariable logistic regression assessed associations of GLP1 use and T2D with GC.

Results

Seventeen participants aged 13-21 underwent gastric ultrasound (13 on GLP1 [7 with T2D, 6 without]; 4 not on GLP1 [1 with T2D, 3 without]). Characteristics/findings are summarized in Table 1. In multivariable logistic regression, GLP1 use was not significantly associated with the presence of GC (OR 1.33, 95% CI 0.10-17.10, p=0.83). When adjusted for GLP1 use, T2D status was also not significantly associated with presence of GC (OR 0.61, 95% CI 0.07-5.4, p=0.66).

Conclusion

GLP1 use was associated with higher but non-significant odds of GC, with no difference by T2D status. More participants are needed to clarify the impact of GLP1 use on gastric emptying in pediatric preoperative care. Disclosure N. Segev: None. I.G. Allen: None. N. Yayah Jones: Consultant; Current; Medtronic, Sanofi. A. Shah: Consultant; Ended; AbbVie Inc. S. Narayanasamy: None.

Zitieren

APA

SEGEV, N., ALLEN, I. G., JONES, N. Y., SHAH, A., & NARAYANASAMY, S. (2026). 2071-P: Gastric Emptying in Youth on Glucagon-Like Peptide 1 Receptor Agonists. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2071-p

Vancouver

SEGEV N, ALLEN IG, JONES NY, SHAH A, NARAYANASAMY S. 2071-P: Gastric Emptying in Youth on Glucagon-Like Peptide 1 Receptor Agonists. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2071-p

BibTeX
@article{SEGEV2026,
  author = {SEGEV, NATALIE and ALLEN, ISABELLE G. and JONES, NANA YAYAH and SHAH, AMY and NARAYANASAMY, SURYAKUMAR},
  title = {2071-P: Gastric Emptying in Youth on Glucagon-Like Peptide 1 Receptor Agonists},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2071-p}
}
Kostenlos starten →